InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,654.32
(
1.25%
)
US TECH 100
19,947.60
(
1.37%
)
Dow Jones
40,228.46
(
1.19%
)
Brent Oil
84.77
(
-0.41%
)
Bitcoin
58,192.44
(
1.48%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

icebrg

Send PM Follow Ignore
Followers 4
Posts 165
Boards Moderated 0
Alias Born 09/19/2004

icebrg

Re: DewDiligence post# 4450

Friday, 08/03/2007 2:04:55 PM

Friday, August 03, 2007 2:04:55 PM

Post# of 19309
I’m somewhat surprised by today’s CD20 announce-
ment because it takes guts to go head-to-head against
Genentech and BIIB, who are co-developing a second-
generation CD20 mAb called Ocrelizumab:

Further, there is a Genmab/GSK CD20 mAb in phase III.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up